EV/EBITDA
-1.19
-0.04-3.48%
Tue, 03 Dec 2024 14:30:00 GMT
Summary:
Plus Therapeutics EV/EBITDA is currently -1.19, with a fall of -0.04 (-3.48%) during the most recent trading day. Over the past year, it has dropped by -0.89 (-296.67%). PSTV EV/EBITDA is now -102.90% below its all-time high of 40.98.PSTV EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PSTV EV/EBITDA Performance
PeriodPeriod | EV/EBITDAEV/EBITDA |
---|---|
todaytoday | -3.5% |
1 m1 month | +0.8% |
3 m3 months | +9.2% |
6 m6 months | +6.3% |
ytdytd | -325.0% |
1 y1 year | -296.7% |
5 y5 years | -8.2% |
PSTV EV/EBITDA High & Low
PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
---|---|---|---|---|---|
1 m | 1 month | -1.07 | -11.2% | -1.25 | +4.8% |
3 m | 3 months | -1.07 | -11.2% | -1.49 | +20.1% |
6 m | 6 months | -0.74 | -60.8% | -1.56 | +23.7% |
1 y | 1 year | -0.28 | -325.0% | -1.70 | +30.0% |
3 y | 3 years | 0.32 | -471.9% | -1.70 | +30.0% |
5 y | 5 years | 33.24 | -103.6% | -10.28 | +88.4% |
alltime | all time | 40.98 | -102.9% | -20.95 | +94.3% |
Plus Therapeutics EV/EBITDA History
Date | Value |
---|---|
2024 | -1.19(+325.0%) |
2023 | -0.28(-411.1%) |
2022 | 0.09(-122.5%) |
2021 | -0.40(-77.9%) |
2020 | -1.81(-74.2%) |
2019 | -7.01(+298.3%) |
2018 | -1.76(+51.7%) |
2017 | -1.16(-44.2%) |
2016 | -2.08(-27.3%) |
2015 | -2.86(+52.9%) |
2014 | -1.87(-81.4%) |
2013 | -10.08(+51.6%) |
Date | Value |
---|---|
2012 | -6.65(+72.3%) |
2011 | -3.86(-63.5%) |
2010 | -10.57(-21.5%) |
2009 | -13.46(+234.0%) |
2008 | -4.03(+12.3%) |
2007 | -3.59(-55.9%) |
2006 | -8.14(+140.1%) |
2005 | -3.39(+62.2%) |
2004 | -2.09(-52.7%) |
2003 | -4.42(+7.8%) |
2002 | -4.10(+1.2%) |
2001 | -4.05 |
FAQ
- What is Plus Therapeutics EV/EBITDA?
- What is the all time high EV/EBITDA for Plus Therapeutics?
- What is PSTV EV/EBITDA year-to-date change?
- What is Plus Therapeutics EV/EBITDA year-on-year change?
What is Plus Therapeutics EV/EBITDA?
The current EV/EBITDA of PSTV is -1.19
What is the all time high EV/EBITDA for Plus Therapeutics?
Plus Therapeutics all-time high EV/EBITDA is 40.98
What is PSTV EV/EBITDA year-to-date change?
Plus Therapeutics EV/EBITDA has changed by -0.91 (-325.00%) since the beginning of the year
What is Plus Therapeutics EV/EBITDA year-on-year change?
Over the past year, PSTV EV/EBITDA has changed by -0.89 (-296.67%)